Annual Report

Overview

The report describes Jenscare's 2024 progress in global medical-device commercialization and structural-heart innovation. LuX-Valve Plus advanced through international clinical validation, including completion of European trial enrollment and one-year follow-up work. Ken-Valve received NMPA approval and moved into commercialization preparation. The ESG disclosures report 211 active employees and approximately 841.8 tCO2e of total GHG emissions.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services